2023 annual financial data
MBX Biosciences 2023 Operating margin
MBX Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -35,311,000 USD and net income was -32,563,000 USD.
Operating cash flow was -31,978,000 USD.
Get free MBX Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -35,311,000 USD
- Net income
- -32,563,000 USD
- Operating cash flow
- -31,978,000 USD